{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:54:41Z","timestamp":1772150081634,"version":"3.50.1"},"reference-count":39,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.3892\/mmr.2013.1309","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T13:00:56Z","timestamp":1360155656000},"page":"1336-1342","source":"Crossref","is-referenced-by-count":19,"title":["Pioglitazone inhibits high glucose-induced synthesis of extracellular matrix by NF-\u03baB and AP-1 pathways in rat peritoneal mesothelial cells"],"prefix":"10.3892","volume":"7","author":[{"given":"GUANGYU","family":"ZHOU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XUESONG","family":"SU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIANFEI","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LINING","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DETIAN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,2,6]]},"reference":[{"key":"key20180108011538_b1-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-94-011-0814-0_2","article-title":"Ultrastructure and pathology of the peritoneal dialysis","volume-title":"The Textbook of Peritoneal Dialysis","author":"Dobbie","year":"1994","edition":"3rd edition"},{"issue":"Suppl 2","key":"key20180108011538_b2-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"S585","DOI":"10.1177\/089686089301302S145","article-title":"Peritoneal ultrastructure and changes with continuous ambulatory peritoneal dialysis","volume":"13","author":"Dobbie","year":"1993","journal-title":"Perit Dial Int"},{"key":"key20180108011538_b3-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1523-1755.2003.00113.x","article-title":"Emodin ameliorates glucose- induced matrix synthesis in human peritoneal mesothelial cells","volume":"64","author":"Chan","year":"2003","journal-title":"Kidney Int"},{"key":"key20180108011538_b4-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1744-9987.2007.00423.x","article-title":"Glucose-based PD solution, but not icodextrin-based PD solution, induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1\/2","volume":"11","author":"Katsutani","year":"2007","journal-title":"Ther Apher Dial"},{"key":"key20180108011538_b5-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.104.475673","article-title":"Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets","volume":"115","author":"Brown","year":"2007","journal-title":"Circulation"},{"key":"key20180108011538_b6-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1523-1755.2004.00574.x","article-title":"Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses","volume":"65","author":"Zafiriou","year":"2004","journal-title":"Kidney Int"},{"key":"key20180108011538_b7-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1093\/ndt\/gfn157","article-title":"Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats","volume":"23","author":"Ko","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108011538_b8-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"F1153","DOI":"10.1152\/ajprenal.00097.2005","article-title":"PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose","volume":"289","author":"Panchapakesan","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20180108011538_b9-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.2001.0590051899.x","article-title":"Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats","volume":"59","author":"Ma","year":"2001","journal-title":"Kidney Int"},{"key":"key20180108011538_b10-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1440-1797.2006.00654.x","article-title":"Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells","volume":"11","author":"Peng","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"key20180108011538_b11-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1159\/000098149","article-title":"Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense","volume":"26","author":"Zhang","year":"2006","journal-title":"Am J Nephrol"},{"key":"key20180108011538_b12-mmr-07-04-1336","first-page":"32","article-title":"Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model","volume":"24","author":"Bozkurt","year":"2008","journal-title":"Adv Perit Dial"},{"key":"key20180108011538_b13-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1159\/000097081","article-title":"Peroxisome proliferator-activated receptor-gamma agonists diminish peritoneal functional and morphological changes induced by bioincompatible peritoneal dialysis solution","volume":"24","author":"Yao","year":"2006","journal-title":"Blood Purif"},{"key":"key20180108011538_b14-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/089686088900900423","article-title":"Isolation and propagation in vitro of peritoneal mesothelial cells","volume":"9","author":"Hjelle","year":"1989","journal-title":"Perit Dial Int"},{"key":"key20180108011538_b15-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1046\/j.1523-1755.1998.00180.x","article-title":"What really happens to people on long-term peritoneal dialysis?","volume":"54","author":"Davies","year":"1998","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"key20180108011538_b16-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1177\/089686080002002S04","article-title":"Effect of high glucose on peritoneal mesothelial cell biology","volume":"20","author":"Ha","year":"2000","journal-title":"Perit Dial Int"},{"issue":"Suppl 3","key":"key20180108011538_b17-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ndt\/17.suppl_3.12","article-title":"Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions","volume":"17","author":"Devuyst","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108011538_b18-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1177\/089686089701702S08","article-title":"Peritoneal dialysis solution biocompatibility: inhibitory mechanisms and recent studies with bicarbonate-buffered solutions","volume":"17","author":"Jorres","year":"1997","journal-title":"Periton Dial Int"},{"key":"key20180108011538_b19-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI200318038","article-title":"A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis","volume":"112","author":"Huang","year":"2003","journal-title":"J Clin Invest"},{"key":"key20180108011538_b20-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1774-9987.2005.00232.x","article-title":"Effects of glucose and plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum","volume":"9","author":"Higuchi","year":"2005","journal-title":"Ther Apher Dial"},{"key":"key20180108011538_b21-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2337\/diabetes.49.6.1022","article-title":"Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats","volume":"49","author":"Isshiki","year":"2000","journal-title":"Diabetes"},{"key":"key20180108011538_b22-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2005.02.029","article-title":"Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats","volume":"329","author":"Pelzer","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108011538_b23-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1248\/bpb.34.618","article-title":"Inhibition of reactive oxygen species\/extracellular signal-regulated kinases pathway by pioglitazone attenuates advanced glycation end products-induced proliferation of vascular smooth muscle cells in rats","volume":"34","author":"Yuan","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"key20180108011538_b24-mmr-07-04-1336","first-page":"6213","article-title":"Anticancer effect of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation","volume":"61","author":"Palakurthi","year":"2001","journal-title":"Cancer Res"},{"key":"key20180108011538_b25-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/gast.2002.33666","article-title":"Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro","volume":"122","author":"Galli","year":"2002","journal-title":"Gastroenterology"},{"key":"key20180108011538_b26-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-2952(99)00296-8","article-title":"Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries","volume":"59","author":"Bowie","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"key20180108011538_b27-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-9440(10)61708-7","article-title":"New insights into the role of nuclear factor-kappaB in cell growth regulation","volume":"159","author":"Chen","year":"2001","journal-title":"Am J Pathol"},{"key":"key20180108011538_b28-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/365182a0","article-title":"Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B","volume":"365","author":"Henkel","year":"1993","journal-title":"Nature"},{"key":"key20180108011538_b29-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/biof.5520100211","article-title":"The role of oxidative stress and NF-kappaB activation in late diabetic complications","volume":"10","author":"Mohamed","year":"1999","journal-title":"Biofactors"},{"key":"key20180108011538_b30-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.2337\/diab.47.8.1318","article-title":"Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats","volume":"47","author":"Nishio","year":"1998","journal-title":"Diabetes"},{"key":"key20180108011538_b31-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/sj.onc.1204385","article-title":"Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity","volume":"20","author":"Chinenov","year":"2001","journal-title":"Oncogene"},{"key":"key20180108011538_b32-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/sj.onc.1204383","article-title":"AP-1 in cell proliferation and survival","volume":"20","author":"Shaulian","year":"2001","journal-title":"Oncogene"},{"key":"key20180108011538_b33-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s001250051680","article-title":"Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose-and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells","volume":"44","author":"Ahn","year":"2001","journal-title":"Diabetologia"},{"key":"key20180108011538_b34-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3858\/emm.2011.43.12.079","article-title":"Inhibition of NF-\u03baB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells","volume":"43","author":"Jeong","year":"2011","journal-title":"Exp Mol Med"},{"key":"key20180108011538_b35-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1152\/ajpendo.00540.2002","article-title":"Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications","volume":"284","author":"Chen","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key20180108011538_b36-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"H1738","DOI":"10.1152\/ajpheart.00341.2006","article-title":"Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone","volume":"291","author":"Chen","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key20180108011538_b37-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"C263","DOI":"10.1152\/ajpcell.00192.2002","article-title":"High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1","volume":"284","author":"Chen","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"key20180108011538_b38-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.virol.2005.11.009","article-title":"Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells","volume":"346","author":"Arnold","year":"2006","journal-title":"Virology"},{"key":"key20180108011538_b39-mmr-07-04-1336","doi-asserted-by":"crossref","first-page":"34176","DOI":"10.1074\/jbc.M203436200","article-title":"Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2013.1309\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T23:19:36Z","timestamp":1595373576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2013.1309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,6]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,2,6]]},"published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.3892\/mmr.2013.1309"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2013.1309","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,6]]}}}